Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
215 USD | -0.64% | -2.55% | -16.87% |
Mar. 25 | Dyne Therapeutics President, CEO Joshua Brumm Resigns, John Cox Named Successor; Shares Drop 7% Pre-Bell | MT |
Mar. 19 | BIOGEN : Jefferies confirms its Buy rating on the stock | CF |
- Stock
- Equities
- Stock Biogen Inc. - Nasdaq
- News Biogen Inc.